Page last updated: 2024-08-21

2-phenylpyridine and Atherosclerotic Parkinsonism

2-phenylpyridine has been researched along with Atherosclerotic Parkinsonism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grimes, JD; Hassan, MN; Thakar, JH1
Hansen, S; Jones, K; Perry, TL; Wall, RA1

Other Studies

2 other study(ies) available for 2-phenylpyridine and Atherosclerotic Parkinsonism

ArticleYear
Behavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents.
    Advances in neurology, 1990, Volume: 53

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain; Corpus Striatum; Dopamine; Male; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; Oxidative Phosphorylation; Parkinson Disease, Secondary; Pyridines; Rats; Rats, Inbred Strains; Receptors, Dopamine

1990
2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease.
    Journal of the neurological sciences, 1988, Volume: 85, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Mice; Mice, Inbred C57BL; Neurotoxins; Parkinson Disease, Secondary; Pyridines; Reference Values; Tea

1988